Benjaminy相关文献与解析，生知库 | 链接生命科学的每一步

A blueprint for the next generation of ELSI research, training, and outreach in regenerative medicine

下一代再生医学伦理、法律和社会影响（ELSI）研究、培训和推广的蓝图

Illes, Judy; Sipp, Douglas; Kleiderman, Erika; Benjaminy, Shelly; Isasi, Rosario; Lomax, Geoff; Master, Zubin; McCormick, Jennifer; Ogbogu, Ubaka; Ravitsky, Vardit; Robillard, Julie M; Rossi, Fabio; Wilson, Brenda; Zarzeczny, Amy

发育与干细胞

发表日期：2017

文献求助收藏

Research ethics and stem cells: Is it time to re-think current approaches to oversight?

研究伦理与干细胞：是否应该重新思考当前的监管方法？

期刊:EMBO Reports

影响因子:6.2

doi:10.15252/embr.201439819

Caulfield, Timothy; Kamenova, Kalina; Ogbogu, Ubaka; Zarzeczny, Amy; Baltz, Jay; Benjaminy, Shelly; Cassar, Paul A; Clark, Marianne; Isasi, Rosario; Knoppers, Bartha; Knowles, Lori; Korbutt, Gregory; Lavery, James V; Lomax, Geoffrey P; Master, Zubin; McDonald, Michael; Preto, Nina; Toews, Maeghan

"You don't want to lose that trust that you've built with this patient...": (dis)trust, medical tourism, and the Canadian family physician-patient relationship

“你不想失去你和这位病人之间建立起来的信任……”：信任（或不信任）、医疗旅游以及加拿大全科医生与病人之间的关系

期刊:BMC Family Practice

影响因子:3.2

doi:10.1186/s12875-015-0245-6

Crooks, Valorie A; Li, Neville; Snyder, Jeremy; Dharamsi, Shafik; Benjaminy, Shelly; Jacob, Karen J; Illes, Judy

发表日期：2015

文献求助收藏

"Is a cure in my sight?" Multi-stakeholder perspectives on phase I choroideremia gene transfer clinical trials

“治愈的曙光就在眼前吗？”多方利益相关者对脉络膜萎缩症基因转移I期临床试验的看法

期刊:Genetics in Medicine

影响因子:6.2

doi:10.1038/gim.2013.148

Benjaminy, Shelly; Macdonald, Ian; Bubela, Tania

发表日期：2014

文献求助收藏

Ocular gene transfer in the spotlight: implications of newspaper content for clinical communications

眼部基因转移成为关注焦点：报纸内容对临床传播的影响

期刊:BMC Medical Ethics

影响因子:3.1

doi:10.1186/1472-6939-15-58

Benjaminy, Shelly; Bubela, Tania

发表日期：2014

文献求助收藏

Perspectives About Time Frames in Stem Cell Research for Multiple Sclerosis: "Time Is Brain"

关于多发性硬化症干细胞研究时间框架的观点：“时间就是大脑”

Reflections on translation: Views of participants in a multisite Canadian CCSVI clinical trial

关于翻译的反思：加拿大多中心CCSVI临床试验参与者的观点

Resilience, trust, and civic engagement in the post-CCSVI era

后CCSVI时代的韧性、信任和公民参与

A blueprint for the next generation of ELSI research, training, and outreach in regenerative medicine

下一代再生医学伦理、法律和社会影响（ELSI）研究、培训和推广的蓝图

Research ethics and stem cells: Is it time to re-think current approaches to oversight?

研究伦理与干细胞：是否应该重新思考当前的监管方法？

"You don't want to lose that trust that you've built with this patient...": (dis)trust, medical tourism, and the Canadian family physician-patient relationship

“你不想失去你和这位病人之间建立起来的信任……”：信任（或不信任）、医疗旅游以及加拿大全科医生与病人之间的关系

"Is a cure in my sight?" Multi-stakeholder perspectives on phase I choroideremia gene transfer clinical trials

“治愈的曙光就在眼前吗？”多方利益相关者对脉络膜萎缩症基因转移I期临床试验的看法

Ocular gene transfer in the spotlight: implications of newspaper content for clinical communications

眼部基因转移成为关注焦点：报纸内容对临床传播的影响